Vartoukian et al. showed that overexpression of pro-inflammatory cytokine IL-17 in SS patients was due to reduction of suppressor of cytokine signaling 3 (SOCS3), which is a negative regulator for the JAK/STAT3/IL-17 pathway [76]. The gene discussed is IL17A; the disease is synovial sarcoma.